Page last updated: 2024-10-24

bupivacaine and Chronic Paroxysmal Hemicrania

bupivacaine has been researched along with Chronic Paroxysmal Hemicrania in 1 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Androulakis, XM1
Krebs, KA1
Ashkenazi, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Sphenopalatine Ganglion Block for the Treatment of Post-Stroke Headache[NCT05365880]Phase 220 participants (Anticipated)Interventional2022-03-23Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for bupivacaine and Chronic Paroxysmal Hemicrania

ArticleYear
Hemicrania continua may respond to repetitive sphenopalatine ganglion block: A case report.
    Headache, 2016, Volume: 56, Issue:3

    Topics: Anesthetics, Local; Bupivacaine; Female; Humans; Middle Aged; Minimally Invasive Surgical Procedures

2016